Freezing Ovarian Tissue to Preserve Fertility in Young Women With Cancer
Tests freezing and later returning ovarian tissue to females with cancer, to help preserve fertility.
Plain-language title generated from the registry record
Registry title: Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Prince of Wales HospitalHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chinese University of Hong Kong
- Trial code
- NCT05830929
- Record updated
- 7 January 2026
- Original description
Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.Read full original descriptionShow less
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.
Inclusion: Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients; Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments; Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future.
Exclusion: Patients with no anticipated oncologic therapies; Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay); Patients who are pregnant; Children with one ovary; Children deemed high risk for perioperative complications.